01.16.13
XSTO Solutions, Morristown, NJ, and its Japan-based manufacturing partner Hamari Chemicals, have agreed to a multiyear exclusive distribution agreement for BenfoPure brand Benfotiamine in the U.S. This follows the recent designation of self-GRAS (Generally Recognized As Safe) via Hamari’s assembling of an independent panel of experts. XSTO will utilize the new GRAS designation to introduce BenfoPure Benfotiamine to the U.S. nutrition market as the only source of Benfotiamine with a regulatory status. BenfoPure is currently sold in Japan, Europe and other parts of the world. Benfotiamine is widely recognized for supporting healthy sugar metabolism, through a unique mode of action that reduces the negative impact of excess sugar in the diet.
